HIND
HIND
NASDAQ · Pharmaceuticals

Vyome Holdings Inc

$1.96
-0.07 (-3.45%)
As of May 9, 2:21 AM ET ·
Day Range $1.96 — $2.09
52W Range $1.75 — $37.44
Open$2.04
Previous Close$2.03
Day High$2.09
Day Low$1.96
52W High$37.44
52W Low$1.75
Volume
Avg Volume24.4K
Market Cap14.74M
P/E Ratio
EPS$63.63
SectorPharmaceuticals

Analyst Ratings

Strong Buy
7 analysts
6 Buy 1 Hold 0 Sell
Price Target +875.5% upside
Current
$1.96
Target
$19.12
$13.94 $19.12 avg $23.15

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 1.11M 3.64M 5.84M
Net Income -35,704,255 -105,253,290 1.21M
Profit Margin -3,209.8% -3,049.3% 20.8%
EBITDA -36,008,809 -112,048,373 1.81M
Free Cash Flow 575.3K
Rev Growth -69.5% -69.5% -9.0%
Debt/Equity 0.79

Pharmaceuticals Peers

Symbol Name Price Change P/E Mkt Cap
LLY Eli Lilly and Co. $948.45 -2.72% 36.1 913.24B
JNJ Johnson & Johnson $221.32 -0.53% 26.1 548.94B
MRK Merck & Co. Inc. $111.38 -0.82% 31.3 279.42B
PFE Pfizer Inc. $25.68 -3.02% 19.3 150.09B
BMY Bristol-Myers Squibb Co $56.16 -0.16% 17.0 120.08B
ZTS Zoetis Inc $82.83 -5.13% 21.5 57.37B

Next Earnings

May 18, 2026
TBD
7 days away
EPS Est: $-0.18

Quick Stats

Market Cap14.74M
P/E Ratio
EPS$63.63
Volume
SectorPharmaceuticals